Form 144 Zai Lab Ltd Filed by: Du Ying
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Zai Lab (ZLAB) PT Raised to $75 at Leerink Partners
June 30, 2025 1:07 PM EDTLeerink Partners analyst Jonathan Chang raised the price target on Zai Lab (NASDAQ: ZLAB) to $75.00 (from $73.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: ZLAB partner AMGN (MP, Risinger) announced today that the Phase III FORTITUDE-101 study evaluating bemarituzumab in combination with chemotherapy in 1L FGFR2b+... More
